Uso de la ciclobenzapirina vs. tiocolchisido en la evolución de la lumbalgia aguda en los servicios de cirugía y clínica en el Hospital de Yanzatza, Zamora Chinchipe

This study was conducted in order to establish the benefits of two medications as ciclobenzaprina thiocolchicoside and in patients with acute low back pain Basic Yanzatza hospital during the period February to August 2014. We performed a cross-term prospective study to determine the benefits of using ciclobenzaprina vs thiocolchicoside in the clinical management of acute low back pain Yantzaza basic hospital. We studied 80 patients who attended a clinical surgery and the results determined that the total, were 20 women and 60 men, with an average age of 43.3 years, all patients underwent pharmacological treatment of which half were treated with ciclobenzaprina and same with thiocolchicoside. The most common cause of acute low back pain was overexertion with a percentage of 63.75%, the initial EVA patients treated with ciclobenzaprina was 8.32 and the initial EVA treated with thiocolchicoside was de8, one , in terms of adverse effects were most prominent in the drowsiness ciclobenzaprina with 10% and were thiocolchicoside photosensitivity and dizziness at 4%, in terms of final EVA ciclobenzaprina was 1.45 and was thiocolchicoside 2.15, P = 0.075. Can be determined that the ciclobenzaprina treatment is more effective in controlling acute low back pain, relative to thiocolchicoside presence except more adverse effects that differ from the latter drug. KEYWORDS Acute low back pain. Drowsiness, photosensitivity.

• Autor principal: Castillo Alberca, Rocío Madeleine (author)
• Format: bachelorThesis
• Idioma: spa
• Publicat: 2014
• Matèries: LUMBALGIA AGUDA; COLUMNA
• Accés en línia: http://dspace.unl.edu.ec/jspui/handle/123456789/13460